These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 30925083)

  • 1. A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study.
    Christiansen MP; Klaff LJ; Bailey TS; Brazg R; Carlson G; Tweden KS
    Diabetes Technol Ther; 2019 May; 21(5):231-237. PubMed ID: 30925083
    [No Abstract]   [Full Text] [Related]  

  • 2. A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II.
    Christiansen MP; Klaff LJ; Brazg R; Chang AR; Levy CJ; Lam D; Denham DS; Atiee G; Bode BW; Walters SJ; Kelley L; Bailey TS
    Diabetes Technol Ther; 2018 Mar; 20(3):197-206. PubMed ID: 29381090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial.
    Kropff J; Choudhary P; Neupane S; Barnard K; Bain SC; Kapitza C; Forst T; Link M; Dehennis A; DeVries JH
    Diabetes Care; 2017 Jan; 40(1):63-68. PubMed ID: 27815290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study.
    Garg SK; Liljenquist D; Bode B; Christiansen MP; Bailey TS; Brazg RL; Denham DS; Chang AR; Akturk HK; Dehennis A; Tweden KS; Kaufman FR
    Diabetes Technol Ther; 2022 Feb; 24(2):84-92. PubMed ID: 34515521
    [No Abstract]   [Full Text] [Related]  

  • 5. Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes.
    Wadwa RP; Laffel LM; Shah VN; Garg SK
    Diabetes Technol Ther; 2018 Jun; 20(6):395-402. PubMed ID: 29901421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First assessment of the performance of an implantable continuous glucose monitoring system through 180 days in a primarily adolescent population with type 1 diabetes.
    Aronson R; Abitbol A; Tweden KS
    Diabetes Obes Metab; 2019 Jul; 21(7):1689-1694. PubMed ID: 30938036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles.
    Tweden KS; Deiss D; Rastogi R; Addaguduru S; Kaufman FR
    Diabetes Technol Ther; 2020 May; 22(5):422-427. PubMed ID: 31697182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor.
    Sanchez P; Ghosh-Dastidar S; Tweden KS; Kaufman FR
    Diabetes Technol Ther; 2019 Dec; 21(12):677-681. PubMed ID: 31385732
    [No Abstract]   [Full Text] [Related]  

  • 9. Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator.
    Shah VN; Laffel LM; Wadwa RP; Garg SK
    Diabetes Technol Ther; 2018 Jun; 20(6):428-433. PubMed ID: 29923775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose Sensor.
    Christiansen MP; Garg SK; Brazg R; Bode BW; Bailey TS; Slover RH; Sullivan A; Huang S; Shin J; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2017 Aug; 19(8):446-456. PubMed ID: 28700272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of a Fourth-Generation Continuous Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes.
    Slover RH; Tryggestad JB; DiMeglio LA; Fox LA; Bode BW; Bailey TS; Brazg R; Christiansen MP; Sherr JL; Tsalikian E; Kaiserman KB; Sullivan A; Huang S; Shin J; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2018 Sep; 20(9):576-584. PubMed ID: 30063162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Point Accuracy Between Two Widely Used Continuous Glucose Monitoring Systems.
    Hanson K; Kipnes M; Tran H
    J Diabetes Sci Technol; 2024 May; 18(3):598-607. PubMed ID: 38189290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Continuous Glucose Monitoring Accuracy Between Abdominal and Upper Arm Insertion Sites.
    Steineck IIK; Mahmoudi Z; Ranjan A; Schmidt S; Jørgensen JB; Nørgaard K
    Diabetes Technol Ther; 2019 May; 21(5):295-302. PubMed ID: 30994362
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System.
    Deiss D; Szadkowska A; Gordon D; Mallipedhi A; Schütz-Fuhrmann I; Aguilera E; Ringsell C; De Block C; Irace C
    Diabetes Technol Ther; 2019 May; 21(5):254-264. PubMed ID: 31021180
    [No Abstract]   [Full Text] [Related]  

  • 15. New features and performance of a next-generation SEVEN-day continuous glucose monitoring system with short lag time.
    Bailey T; Zisser H; Chang A
    Diabetes Technol Ther; 2009 Dec; 11(12):749-55. PubMed ID: 20001675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance evaluation of a continuous glucose monitoring system under conditions similar to daily life.
    Pleus S; Schmid C; Link M; Zschornack E; Klötzer HM; Haug C; Freckmann G
    J Diabetes Sci Technol; 2013 Jul; 7(4):833-41. PubMed ID: 23911164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multisite Study of an Implanted Continuous Glucose Sensor Over 90 Days in Patients With Diabetes Mellitus.
    Dehennis A; Mortellaro MA; Ioacara S
    J Diabetes Sci Technol; 2015 Jul; 9(5):951-6. PubMed ID: 26224762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Device profile of the eversense continuous glucose monitoring system for glycemic control in type-1 diabetes: overview of its safety and efficacy.
    Irace C; Cutruzzolà A; Tweden K; Kaufman FR
    Expert Rev Med Devices; 2021 Oct; 18(10):909-914. PubMed ID: 34528851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance Comparison of CGM Systems: MARD Values Are Not Always a Reliable Indicator of CGM System Accuracy.
    Kirchsteiger H; Heinemann L; Freckmann G; Lodwig V; Schmelzeisen-Redeker G; Schoemaker M; Del Re L
    J Diabetes Sci Technol; 2015 Sep; 9(5):1030-40. PubMed ID: 26330485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The accuracy and efficacy of real-time continuous glucose monitoring sensor in Chinese diabetes patients: a multicenter study.
    Zhou J; Lv X; Mu Y; Wang X; Li J; Zhang X; Wu J; Bao Y; Jia W
    Diabetes Technol Ther; 2012 Aug; 14(8):710-8. PubMed ID: 22853722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.